Technovation with Peter High (CIO, CTO, CDO, CXO Interviews) Emerging AI Opportunities in Pharmaceuticals and Healthcare with Eli Lilly CIDO Diogo Rau, AstraZeneca CDO & CIO Cindy Hoots, and Bristol Myers Squibb CDTO Greg Meyers
Jun 13, 2024
Join Diogo Rau, former Apple executive and Chief Information and Digital Officer at Eli Lilly, alongside AstraZeneca's Cindy Hoots, a board member at Zoom, and Bristol Myers Squibb's Greg Meyers, ex-CIO at Motorola. They discuss how AI is revolutionizing pharma, tackling clinical trials, and enhancing personalized medicine. The trio emphasizes AI's role in streamlining operations, boosting research efficiency, and addressing workforce challenges. Get the inside scoop on transforming drug development and improving patient care through innovative AI applications!
AI Snips
Chapters
Transcript
Episode notes
Data Quality Powers AI Success
- Effective AI requires excellent data management including cataloging, deduplication, and accessibility of structured and unstructured data.
- Vectorizing documents enables powerful generative AI applications like document question answering.
Build Strong AI Foundations
- Simplify IT systems and move to platform approaches to enable data accessibility and interoperability.
- Establish AI ethics and data governance while empowering citizen data scientists for broader AI adoption.
AI Advances Clinical Trials
- Eli Lilly uses AI in clinical trials by connecting patients to sensors to find patterns and predict outcomes.
- They successfully predicted COVID infection before test results using data from heart rate and activity sensors.